Chapter 14: Strategic Outsourcing and Vendor Governance in Pharmacovigilance
Synopsis
Author
Miss Agnitha Christeena Geddam,
PharmD Scholar, Department of Pharmacy Practice, Sir C.R.Reddy College of Pharmaceutical Sciences, Eluru, Andhra Pradesh, India
Abstract
In the modern pharmaceutical industry, the execution of pharmacovigilance and data management functions is increasingly reliant on external partnerships. The strategic decision-making process behind outsourcing contrasts the traditional Full Service model, where an entire project is handed over to a Contract Research Organization (CRO), with the Functional Service Provider (FSP) model, where dedicated external teams integrate into the sponsor’s internal operations. The lifecycle of vendor management spans from the initial competitive selection process involving Requests for Proposals (RFPs) and rigorous qualification audits to the establishment of binding legal frameworks like the Safety Data Exchange Agreement (SDEA). Effective governance is presented not just as a contractual necessity but as a relationship management skill, emphasizing the need for cultural alignment and transparent communication to prevent operational silos. Quantitative metrics are essential to measure success, distinguishing between Key Performance Indicators (KPIs), which track operational trends, and Service Level Agreements (SLAs), which enforce contractual penalties for non-compliance. This rigorous oversight ensures that the outsourced partner remains accountable for patient safety and regulatory timeliness, maintaining the sponsor's ultimate responsibility for the pharmacovigilance system.
Keywords: Strategic Outsourcing, Functional Service Provider (FSP), Vendor Governance, Service Level Agreements (SLAs), Key Performance Indicators (KPIs)
. 